THC Sensitization Increased Some Receptor Signals While Weakening Another in Rat Cerebellum
In a rat THC-sensitization study, increased receptor-related measurements did not translate into stronger responses at every downstream step. Cerebellar G protein activation increased, yet cannabinoid inhibition of stimulated cAMP accumulation was lost.
Sensitization was the experimental state
Researchers examined cellular events associated with behavioral sensitization rather than simply assuming repeated exposure produces tolerance. Receptor binding increased specifically in the cerebellum. Net agonist-stimulated G protein binding increased in the cerebellum and caudate putamen, while basal binding was unaffected.
The downstream cAMP result diverged
In cerebellar tissue from sensitized rats, the cannabinoid agonist did not inhibit forskolin-induced cAMP accumulation. That group difference was not observed in the caudate putamen. Thus, the two regions with altered G protein responses did not have identical downstream enzyme-system responses.
Additional null findings constrained the model
CREB and AP-1 binding activity did not differ in the examined regions. The authors suggested that pathways beyond the cAMP cascade might participate in cannabinoid sensitization. That is a mechanistic possibility, not proof that one unmeasured pathway accounts for the whole behavioral effect.
This study is a useful counterexample to reading receptor binding as a complete measure of drug sensitivity. Repeated exposure, sensitization and tolerance need to be tied to the actual outcome. The cellular findings do not establish escalating intoxication, permanent injury or a measurable level of impairment in an individual human.
Related: interpreting cannabis tolerance claims.
Research cited
Rubino T; Viganò D; Massi P; Parolaro D. Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization. The European journal of neuroscience (2003). doi:10.1046/j.1460-9568.2003.02452.x. Findings discussed from the study abstract.
